3D Systems (DDD) delivered its strongest operating quarter in some time, but not a clean beat. The company reported a non-GAAP loss of $0.06 per share, matching the consensus estimate but falling short of the Earnings Whisper number of -$0.01, a 500.0% negative surprise against that bar. Revenue of $99.3 million beat the $97.37 million consensus by 2.0% and grew 8.8% year over year, or 10.9% excluding the 2025 software divestitures. Earnings improved 25.0% as the adjusted loss narrowed from $0.08 a year ago. The central tension is clear. The top line accelerated sharply and Adjusted EBITDA turned positive, yet investors who expected near-breakeven EPS were disappointed. The fourth-quarter outlook also implies profitability slips back below zero.
The quality of the quarter deserves a split verdict. On an adjusted basis, the improvement was real. Non-GAAP gross margin rose 420 basis points year over year on a divestiture-adjusted basis to 35.5%. Non-GAAP operating expense fell to $36.1 million from $42.3 million, and Adjusted EBITDA swung $13.1 million to a positive $3.1 million. GAAP results told a different story. The net loss widened to $33.5 million, or $0.21 per share, from $18.1 million, or $0.14. The drivers were $16.2 million of legal and other expense, a $2.9 million asset impairment, $2.3 million of CEO transition costs, and a $6.3 million foreign-exchange loss. Part of the cost improvement also came from research and development, which fell to $10.1 million from $16.0 million. That spending cut flatters near-term margins and could weigh on product development over time.
The operating trajectory is where the bull case gained ground. Growth accelerated from just 1.4% in the second quarter to 10.9%. Industrial revenue swung to growth of 7.7% from a 3.7% decline in Q2, and Healthcare growth roughly doubled to 14.4% from 6.8%. Management said its four strategic markets grew roughly 30% collectively:
- Med Tech
- Dental
- Aerospace & Defense, which grew more than 50% excluding an Air Force program
- Data Center Infrastructure
Printers and parts manufacturing each grew more than 25%, and dental aligner materials recovered to a longer-term run rate. The tone on the call was noticeably more offensive. Management pointed to several developments:
- the opening of its 50,000-square-foot Littleton metal parts facility;
- full shipment of a large rocket investment-casting order;
- larger metal printing platforms advancing in discussions with AI infrastructure and defense customers;
- an expectation that future 10% customers will emerge in those industrial markets.
The forward picture is more complicated than the beat implies. Fourth-quarter revenue guidance of $100 million to $103 million sits above the prior quarter's guide and points to full-year growth approaching mid-single digits. Even so, it came in below Street estimates. The Adjusted EBITDA outlook of -$2 million to breakeven is a step back from Q3's positive $3.1 million. Management attributed the caution to a more muted seasonal spike and more evenly distributed purchasing. Gross margin of 35.5% also trails Q2's 36.7% and Q1's 36.1%. Jewelry and consumer-facing industrial markets are still declining at double-digit rates. Defense program timing may make industrial results lumpy, and Healthcare now has two 10% customers, which adds concentration risk.
Bears have legitimate ammunition on the balance sheet. Total cash and investments of $120.5 million are down from about $129 million at the end of Q2, despite the $53.8 million equity raise completed earlier in the year. Weighted shares outstanding rose to 162.9 million from 125.3 million a year ago. The company also launched a new at-the-market equity program and exchanged its 2030 secured notes for unsecured 2031 notes plus cash and stock. That exchange extends maturities but adds dilution, and management conceded noteholders received a lucrative deal. On the positive side, nine-month operating cash burn improved to $17.5 million from $73.1 million.
Investor sentiment moved meaningfully more positive, rising from -0.20 to +0.08. That shift reflects a market warming to the growth story rather than embracing it. The stock has not followed. At $2.64, shares are down 20.2% since the open following the August report and sit about 5.4% below their $2.79 200-day moving average. The trend readings are mixed: momentum has turned positive, while AVWAP remains negative.
The bottom line is that 3D Systems produced the operating acceleration turnaround skeptics were not positioned for. Revenue growth reached double digits, both segments improved sharply, and Adjusted EBITDA turned positive. However, the quarter missed the whisper, GAAP losses widened on litigation and other charges, and the fourth-quarter guide pulls profitability back toward breakeven. Ongoing dilution also caps per-share upside. The company has made a credible case that demand is recovering. It still has to prove that this recovery can translate into durable, self-funded profitability.